BRAF mutated melanoma: targeted or immunotherapy?
Rodabe N. Amaria
Tremelimumab and durvalumab therapy in lung cancer
Balancing the benefits and costs of immunotherapy in the treatment of lung cancer
How to treat established neuropathy?
Highlights in the development of new therapies and novel drugs in treating melanoma